Skip to main content
Expertise in Alzheimer's Disease

Alzheimer’s Disease research at IU School of Medicine

Alzheimer’s disease research at Indiana University School of Medicine encompasses the full spectrum of research—basic and translational research, drug discovery, testing new therapeutics and clinical research. Faculty investigators have a strong and long-standing commitment to neurodegenerative research and receive generous federal grant awards from the National Institutes of Health as well as international support to advance their research. Collaborative research teams at IU School of Medicine also share resources and facilities that enable interaction and innovation.

State-of-the-art collaborative facilities

The IU Health Neuroscience Center (Goodman Hall) integrates clinical neuroscience (Neurology, Psychiatry, Neurological Surgery, Physical Medicine and Rehabilitation and Neuroradiology) and a clinical research center in one building. The Neuroscience Center is attached to the Neurosciences Research Building, home to the Stark Neurosciences Research Institute, a collaborative organization that advances the discovery of neuroscience-related disease mechanisms and therapeutic strategies across Indiana University campuses throughout the state of Indiana. The Indiana Alzheimer's Disease Research Center, also located within the Neuroscience Center, is one of only 33 centers in the United States solely committed to Alzheimer’s research.

The Indiana Biosciences Research Institute is a public-private partnership that supports the growing biomedical research community within Indianapolis, including creation of novel biotechnology companies.

The Regenstrief Institute develops, conducts and disseminates impactful scientific research in health systems and across communities with a focus on aging through the Center for Aging Research.

full spectrum of research

Basic Science Research

Basic scientists explore the neurobiology and molecular genetics of Alzheimer’s disease and related dementias.

Liana Apostolova, MD meets with a LEADS participant.

Translational and Clinical Research

Investigators build on pre-clinical studies in the lab to test new methods to diagnose and treat Alzheimer’s disease.

a provider helps an elderly patient walk down the hallway using a walker

Clinical Expertise

Clinicians and researchers apply disease discoveries — from bench to bedside —and evaluate their efficacy in the clinic to treat and screen patients.

Alzheimer's disease research objectives

Even after decades of research, very little is known about what goes wrong in a person’s DNA to cause dementia. Researchers in basic science are working to analyze data and identify the root causes of dementia. Without this understanding, scientists can’t begin to formulate effective solutions.

Physician scientists now know that Alzheimer’s disease begins to develop about 20 years prior to the onset of dementia. The current thinking is that available treatments have largely been unsuccessful because the disease is too advanced when they are administered. Investigators at IU School of Medicine envision that Alzheimer’s disease will one day be screened for routinely, just as cholesterol tests are regularly administered to detect potential heart problems decades before a heart attack may occur.

IU School of Medicine has played a major role in bringing some of today’s most commonly prescribed drugs to market—and continues to be a frontrunner in the development and testing of new drugs. Scientists are searching for new potential targets, developing new molecules and testing new interventions. Along with novel drugs, research teams are evaluating lifestyle interventions, including exercise and cognitive training, to slow or prevent dementia.

Researchers at IU School of Medicine study ways to improve the quality of life for both patients and caregivers. Across the United States, more than 15 million people are caring for a family member or close friend suffering from dementia. Although being a caregiver can be rewarding, it can also create physical, emotional and financial burdens.

research partners

Stark Neurosciences Research Institute

Stark Neurosciences Research Institute brings together the scientific community in a dynamic, collaborative organization that advances neuroscience discoveries.

Indiana Alzheimer's Disease Research Center

The Indiana Alzheimer's Disease Research Center was established in 1991 and is one of only 33 centers in the U.S. solely committed to Alzheimer’s research. 

Center for Neuroimaging

 The Center for Neuroimaging at IU School of Medicine, through the collaboration of neurosciences and biomedical imaging sciences, focuses on clinical and translational brain-imaging research. 

Indiana Biosciences Research Institute

Indiana Biosciences Research Institute

The Indiana Biosciences Research Institute (IBRI) is a leading translational research institute that advances academic and industry science through collaboration to improve patient health outcomes.

Support Alzheimer’s disease research

Generous giving supports groundbreaking research and empowers scientists to fulfill their vision. To discuss giving options, contact the Office of Gift Development.